University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment

dc.contributor.authorPop, Mihai
dc.contributor.authorPaulson, Joseph N.
dc.contributor.authorChakraborty, Subhra
dc.contributor.authorAstrovskaya, Irina
dc.contributor.authorLindsay, Brianna R.
dc.contributor.authorLi, Shan
dc.contributor.authorCorrada Bravo, Héctor
dc.contributor.authorHarro, Clayton
dc.contributor.authorParkhill, Julian
dc.contributor.authorWalker, Alan W.
dc.contributor.authorWalker, Richard I.
dc.contributor.authorSack, David A.
dc.contributor.authorStine, O. Colin
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.date.accessioned2016-06-09T15:40:03Z
dc.date.available2016-06-09T15:40:03Z
dc.date.issued2016-06-08
dc.descriptionAcknowledgements The authors wish to thank Mark Stares, Richard Rance, and other members of the Wellcome Trust Sanger Institute’s 454 sequencing team for generating the 16S rRNA gene data. Lili Fox Vélez provided editorial support. Funding IA, JNP, and MP were partly supported by the NIH, grants R01-AI-100947 to MP, and R21-GM-107683 to Matthias Chung, subcontract to MP. JNP was partly supported by an NSF graduate fellowship number DGE750616. IA, JNP, BRL, OCS and MP were supported in part by the Bill and Melinda Gates Foundation, award number 42917 to OCS. JP and AWW received core funding support from The Wellcome Trust (grant number 098051). AWW, and the Rowett Institute of Nutrition and Health, University of Aberdeen, receive core funding support from the Scottish Government Rural and Environmental Science and Analysis Service (RESAS).en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent3792825
dc.identifier68244034
dc.identifier7af75759-03ec-456a-830c-0463241699d9
dc.identifier84975761163
dc.identifier.citationPop, M, Paulson, J N, Chakraborty, S, Astrovskaya, I, Lindsay, B R, Li, S, Corrada Bravo, H, Harro, C, Parkhill, J, Walker, A W, Walker, R I, Sack, D A & Stine, O C 2016, 'Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment', BMC Genomics, vol. 17, 440, pp. 1-11. https://doi.org/10.1186/s12864-016-2777-0en
dc.identifier.doi10.1186/s12864-016-2777-0
dc.identifier.issn1471-2164
dc.identifier.otherORCID: /0000-0001-5099-8495/work/42316350
dc.identifier.urihttp://hdl.handle.net/2164/6094
dc.identifier.vol17en
dc.language.isoeng
dc.relation.ispartofBMC Genomicsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectdiarrheaen
dc.subjectenterotoxigenic Escherichia colien
dc.subject16S rRNA gene surveyen
dc.subjectmicrobiotaen
dc.subjectantibiotic treatmenten
dc.subjectQR Microbiologyen
dc.subjectWellcome Trusten
dc.subject098051en
dc.subject.lccQRen
dc.titleIndividual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatmenten
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
art_3A10.1186_2Fs12864_016_2777_0.pdf
Size:
3.62 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: